In order to achieve new aggressive blood pressure goals in hypertensive patients, drug combinations are often used. But which combinations are superior for preventing cardiovascular events?
Invasive coronary angiography (ICA) is the gold standard for assessment of epicardial coronary artery disease. There is much interest in non-invasive alternatives to ICA to assess coronary arteries in order to eliminate the complications associated with arterial access and catheter manipulation during ICA.
Khan et al report a multicenter trial comparing pulmonary vein isolation vs AV junctional ablation with biventricular pacing in patients with atrial fibrillation and heart failure.
The Microvolt t-wave Alternans Testing for risk Stratification of Post-Myocardial Infarction Patients (MASTER) trial tested the hypothesis that microvolt T-wave alternans (MTWA) testing could successfully predict arrhythmia occurrence in patients receiving an ICD for primary prevention of sudden cardiac death.
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
JUPITER, a trial first presented november 9, 2008, at the american Heart Association meeting in New Orleans, was clearly "the bell of the ball," with multiple television, newspaper, and medical journal reports.
Leaders of the American Diabetes Association (ADA) joined with leaders of the European Association for the Study of Diabetes to reconsider the treatment strategy for patients with Type 2 diabetes.
